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Mitochondrial haplogroup B increases the risk
for hearing loss among the Eastern Asian
pedigrees carrying 12S rRNA 1555A>G
mutation
Dear Editor,
Hearing loss is one of the major public health problems. The
mitochondrial DNA mutations has been found to be associ-
ated with both aminoglycoside-induced and nonsyndromic
hearing loss (Fischel-Ghodsian, 1999; Guan, 2011). The
1555A>G mutation in mitochondrial small subunit ribosomal
RNA (rRNA) gene contributes to nonsyndromic hearing loss
and is prevalent in Asian and other populations (Guan, 2011).
This mutation was ﬁrst identiﬁed in families with aminogly-
coside-induced deafness, and the ototoxic susceptibility was
attributed to enhanced binding afﬁnity to aminoglycosides of
1555A>G rRNA (Qian and Guan, 2009). In the absence of
aminoglycoside antibiotics, individuals with 1555A>G muta-
tion exhibit various clinical phenotype that ranges from severe
congenital deafness, through moderate progressive hearing
loss of late onset, to completely normal hearing (Lu et al.,
2010a). The precise pathology remains unclear; however, it is
now largely accepted that genetic susceptibility factors exist
and may interact with environmental exposures, leading to the
development of hearing loss (Chen et al., 2015; Guan, 2011).
Recent studies have suggested that 1555A>G mutation is
of multiple origins, and occurred sporadically among Eastern
Asian and European lineages (Lu et al., 2010b). In addition,
there are increasing evidence indicated that mtDNA hap-
logroups deﬁned by distinct sets of mtDNA variants may
confer genetic resistance against or susceptibility to certain
diseases such as visual failure, diabetes and Parkinson
disease (Fuku et al., 2007; Hudson et al., 2007; Khusnutdi-
nova et al., 2008). In this study, we aimed to investigate
whether mtDNA haplogroups confer susceptibility to hearing
loss in Eastern Asia population carrying 1555A>G mutation.
Comprehensive physical evaluationwere performedamong
11 probands and members of these Han Chinese pedigrees
carrying 1555A>G mutation, and the results revealed that
hearing impairment was the only clinical presentation. As
shown in Fig. S1, 37 of the 107 matrilineal relatives exhibited
bilateral hearing impairment with variable severity ranged from
profound, severe, moderate to mild hearing loss, and 11 sub-
jects had a history of aminoglycoside exposure. In addition,
variable penetrance of hearing loss were observed among
these pedigrees, ranged from 12.5% to 100.0%, with an aver-
age of 41.0%.When aminoglycoside-induced hearing losswas
excluded, the penetrance of hearing loss in these pedigrees
ranged from 0% to 100.0%, with the average of 26.0%.
Through mutational analysis of complete mtDNA gen-
ome, we identiﬁed a total of 192 variants in mtDNA among
the 11 probands, including 48 polymorphisms in D-loop
region, 23 variants in 12S rRNA and 16S rRNA, 6 variants in
tRNA genes, 75 silent variants and 36 missense mutations in
protein encoding genes, and 3 polymorphisms in non-coding
region (Table S1). Furthermore, according to their distinct
clusters of mtDNA polymorphisms, we found the mtDNAs of
11 pedigrees belonged to 4 common eastern Asian mtDNA
haplogroups A, B, D and F.
Besides the 11 families with hearing loss above, we col-
lected additional 131 pedigrees carrying 1555 A>G mutation
among eastern Asian population from previous publications
for further analysis. Of the 142 mtDNAs analyzed, 74 were
categorized into macro-haplogroup M, and the rest 68 pedi-
grees’ mtDNAs were assigned to macro-haplogroup N.
mtDNA haplogroup distribution analysis showed that
1555A>G mutation was widely dispersed among 11 major
Eastern Asian haplogroups D, M7, M8, M10, M11, G, F, B, R,
A and N9 (Fig. S2 and Table S2). This observation strongly
indicated that the 1555A>Gmutation arising independently in
different mtDNA haplogroup backgrounds among eastern
Asian populations. As shown in Table 1, the haplogroup D
was most prevalent in pedigrees with 1555A>G mutation,
which was signiﬁcantly higher than control group (OR = 2.10;
95% CI = 1.38–3.25; P < 0.01). Furthermore, the increased
frequency of 1555A>G mutation on haplogroup D back-
ground is attributable largely to speciﬁc subhaplogroup D5
(OR = 2.92; 95% CI = 1.52–5.61; P < 0.01). In contrast, those
families on haplogroup M8 and G background tended to have
a reduced frequency of 1555A>G mutation (P < 0.05).
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To further understand the role of mtDNA haplogroup on
phenotypic expression for 1555A>G mutation, we evaluated
the penetrance of hearing loss among 142 pedigrees
(Table S3). A wide range of the penetrance of hearing loss
were observed among the 142 pedigrees, with the average of
33.8% and 21.8% when aminoglycosides-induced hearing
loss was included or excluded, respectively. Then the clinical
penetrance of 1555A>G mutation on speciﬁc haplogroup
were compared with that on all mtDNA backgrounds (Fig. 1).
When aminoglycosides-induced hearing loss was included,
we found 22 1555A>G pedigrees with haplogroup B back-
ground (50.7%), which is signiﬁcantly higher than reference
group (P = 0.006). Furthermore, when the aminoglycosides-
exposed hearing loss cases were excluded, these haplogroup
B pedigrees still showed signiﬁcantly higher penetrance of
hearing loss symptom (Average 35.6%, P = 0.0031).
mtDNA haplogroups, as a product of ancient adaptation
to environment, were formed during the evolution and
migration of modern human and presented continental
speciﬁc distributions (Wallace, 2005). According to the
ancestral-susceptibility model, some mtDNA haplogroups
may confer certain disease susceptibility, as well as the
penetrance of the clinical phenotype, with the change of
environment and lifestyle in modern time (Wallace, 2005).
Nuclear–mitochondrial crosstalk is critical for the mainte-
nance of cellular homeostasis. As the mtDNA haplogroups
were characterized by distinct sets of variants, it is not sur-
prising that certain mtDNA haplogroups could affect respi-
ratory chain functions and may further perturb the crosstalk
signaling. Indeed, a number of recent studies have revealed
the associations between speciﬁc mtDNA haplogroups and
various medical conditions such as Leber hereditary optic
neuropathy, Parkinson disease, and Alzheimer’s disease
(Hudson et al., 2007; Khusnutdinova et al., 2008; Malkki,
2013). The 1555A>G mutation is of multiple origins, and
some speciﬁc haplogroups were found to be predominant
among different ethnic backgrounds (Guan, 2011). Among
Spanish pedigrees, the 1555A>G mutation resided at the
mtDNA haplogroups H, I, J, K, T, U, V and L, and a strong
excess of haplogroups H3 mtDNA carrying the 1555A>G
Table 1. Distribution and frequency of mtDNA haplogroup in 1555A>G carriers and controls from Eastern Asia
Haplogroup Hearing-impaired subjects (%) Controls (%) P Valuea OR (95% CI)c
M 74 (52.1) 176 (46.8) 0.3244
D 52 (36.6) 81 (21.5) 0.0007b 2.10 (1.38–3.21)
D4 30 (21.1) 58 (15.4) 0.1486
D5 20 (14.1) 20 (5.3) 0.0015 2.92 (1.52–5.61)
M7 10 (7.0) 26 (6.9) 1.0000
M8 5 (3.5) 40 (10.6) 0.0085 0.31 (0.12–0.79)
M9 0 (0) 6 (1.6) 0.1594
M10 1 (0.7) 5 (1.3) 1.0000
M11 1 (0.7) 2 (0.5) 1.0000
G 4 (2.8) 16 (4.3) 0.0341 0.29 (0.095–0.89)
N 68 (47.9) 200 (53.2) 0.3244
A 9 (6.3) 25 (6.6) 1.0000
R 48 (33.8) 142 (37.8) 0.4157
B 22 (15.5) 70 (18.6) 0.4417
B4 14 (9.9) 46 (12.2) 0.5389
B5 7 (4.9) 22 (5.9) 0.8341
F 23 (16.2) 60 (16.0) 1.0000
F1 8 (5.6) 32 (8.5) 0.3566
F2 7 (4.9) 19 (5.1) 1.0000
F3 4 (2.8) 5 (1.3) 0.2664
N9 10 (7.0) 32 (8.5) 0.7187
N9a 7 (4.9) 30 (8.0) 0.2575
Total subjects 142 376
a P values were calculated by Chi-square test or Fisher’s exact test.
b Signiﬁcant differences (P-value < 0.05) are shown in bold.
c OR indicates odds ratio; 95% CI, 95% conﬁdence interval.
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mutation appeared in these families (Achilli et al., 2004).
Here, we evaluate the contribution of mtDNA haplogroups to
and expression of the hearing loss phenotype caused by
1555A>G mutation in Eastern Asian population.
Lineages M and N radiated to give rise to a plethora of
mtDNA lineages in Asia. Here, the 142 pedigrees carrying the
1555A>G mutation were sporadically distributed among 11
major Asian mtDNAs haplogroups. Alternatively, in keeping
with previous reports that the presence of 1555A>G mutation
has occurred multiple times during evolution of mtDNA in
Eastern Asia (Lu et al., 2010b). MtDNA haplogroup D, one of





























































Figure 1. Effect of mtDNA haplogroup on the penetrance of hearing loss in pedigrees with 1555A>G mutation. P values were
calculated by unpaired two tailed t-test. The haplogroups shared by at least three pedigrees were considered, and the M10 and M11
haplogroups were excluded. One family on haplogroup D was excluded since the lack of the penetrance of hearing loss. Five families
were excluded since the lack of the penetrance of hearing loss without exposure to drugs.
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Asian populations, has been reported to be associated with
various diseases. For instance, the speciﬁc haplogroup D,
and its subgroup D4a and D5 might be susceptibility genetic
background markers for breast cancer and esophageal can-
cer in Chinese population (Fang et al., 2010). In particular, a
previous investigation suggested that haplogroup D4b and its
subgroup D4b2 background has an increased risk of hearing
loss in Japanese population (Kato et al., 2012). Here, we also
found a signiﬁcant excess of haplogroup D population com-
paring to the controls. There are some possible explanations
associated with this observation. First, haplogroup D might
increase the penetrance of 1555A>G mutation, thereby
increasing the detection rate of this haplogroup in subjects
with 1555A>G mutation. However, when we look into the
penetrance of hearing loss in these 1555A>G mutation
pedigrees, no statistic difference was observed comparing the
haplogroup D population with others. Second, the high fre-
quency of the 1555A>G mutation with haplogroup D might be
the result of a founder effect. That is, one 1555A>G mutation
occurred on a speciﬁc D mtDNA, and latter maternally
transmitted by generations to generations with the hearing-
impaired phenotype. In fact, 1555A>G mutation have also
been reported to be an important founder event with H3
haplogroup among Spanish pedigrees (Achilli et al., 2004).
Instead, these subjects with haplogroup B background
exhibited signiﬁcantly higher penetrance of hearing loss.
Haplogroup B is identiﬁed by a 9-bp deletion in the COII/
tRNALys intergenic region of mtDNA plus the HVS I motif
16189–16519. Previous studies have shown that the individ-
uals on haplogroup B background are particularly susceptible
to acute mountain sickness, and greatly increasing the
severity of the clinical symptom in southwestern Han Chinese
population (Li et al., 2011). In addition, the haplogroup B2
increased the risk for cervical cancer and showed an additive
effect over the risk conferred by the human papillomavirus in
Amerindian. In the present study, Pearson’s chi-square test
revealed no signiﬁcant difference of mtDNA haplogroup B
prevalence between the 1555A>G and non-1555A>G popu-
lations. However, combination of the haplogroup B with the
1555A>G mutation signiﬁcantly enhances the penetrance of
hearing loss. Our results suggested that haplogroup B was
associated with a signiﬁcantly increased penetrance of hear-
ing loss whenever aminoglycosides-induced hearing loss
cases were included or excluded.
In conclusion, our ﬁnding suggest that the B haplogroup is
associated with the increased penetrance of hearing loss
phenotype in Asian population with 1555A>G mutation. The
underlying mechanism is worthwhile to investigate further.
Genotyping of these mtSNPs may provide information for
predicting the genetic risk for hearing loss and may thereby
contribute to the primary prevention of clinical syndrome in
these population carrying 1555A>G mutation.
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